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Summary: An enzymatic method for mannitol quantitation has been developed. Its application in determining man-
nitol levels in serum samples from dogs after mannitol infusion is illustrated.
The method is based on the spectrophotometric measurement of the initial rate of NADH formation in the reaction
between mannitol and NAD catalyzed by mannitol dehydrogenase. A linear relationship between initial rates and
mannitol concentration is seen between 17 jumol/1 and 6.7 mmol/1 mannitol. From the extent of dilution of the
serum sample in the assay this corresponds to serum levels of 0.5 to 200 mmol/1.
Because of the high degree of substrate specificity of mannitol dehydrogenase and the extensive dilution of the
serum sample in.the assay reaction mixture, serum proteins and glucose do not interfere with the reaction. As a re-
sult, pre-treatment of samples to remove glucose and deproteinization are unnecessary.
Verbesserte enzymatische Methode zur Bestimmung von Mannit und ihre Anwendung auf Serum vom Hund nach
Mannitinfusipn
Zusammenfassung: Eine Methode zur quantitativen Bestimmung von Mannit wurde entwickelt. Ihre Anwendung zur
Bestimmung der Männitkonzentration in Serumproben vom Hund nach Mannitinfusion wird dargestellt.
Die Methode beruht auf der spektrophotometrischen Messung der Anfangsgeschwindigkeit der NADH-Bildung in der
durch Männitdehydrogenase katalysierten Reaktion zwischen Mannit und NAD. Eine lineare Beziehung besteht zwi-
schen den Anfangsgeschwindigkeiten und Mannitkonzentrationen zwischen 17 / und 6,7 mmol/1. Dies ent-
spricht unter Berücksichtigung der Verdünnung der Serumprobe im Bestimmungsansatz Konzentrationen von 0,5—
200 rnmol/1 Serum.
Wegen der hohen Substratspezifität von Männitdehydrogenase und der erheblichen Verdünnung der Serumprobe im
Bestunmungsansatz stören Serumproteine und Glucose die Reaktion nicht. Daher ist eine Vorbehandlung der Proben
zur Entfernung von Glucose und Enteiweißung nicht erforderlich.
introduction sure (1,2), cerebral edema (3, 4) and post-trauma respi-
There is a large body of evidence to document the effects ry ^ '"
of mannitol on vascular resistance and plasma osmotic However, relationships between mannitol dosage and
pressure in experimental animals (1, 2). The infusion of rate of delivery, plasma osmotic pressure and therapeu-
mannitql has been prescribed in a wide variety of clini- tic effectiveness have been difficult to establish in ani-
cal situations including drug intoxication, refractory ede- mal studies and during the course of clinical treatment,
ma, oliguric renal failure and increased intra-ocular pres- One reason for this has been the lack of data on manni-
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tol pharmacokinetics. This latter problem could be alle-
viated by the development of a rapid and relatively
simple method for measuring serum mannitol levels.
A colorimetric method based on the measurement of
formaldehyde formed by periodic acid oxidation of
mannitol has been used (6, 7) and, more recently, gas-
liquid Chromatographie procedures have been develop-
ed (8-13). However, in the majority of cases, the appli-
cation of these methods to biological samples is techni-
cally rather difficult and time consuming, requiring
sample deproteinization and, in the latter procedures,
the conversion of mannitol to a volatile derivative sui-
table for chromatography (8-10).
It has been known for a number of years that a highly
specific mannitol dehydrogenase (mannitol: nicotina-
mide adenine dinucleotide 2-oxidoreductase; EC 1.1.1.
67) from bacteria will catalyze the NAD-linked oxida-
tion of mannitol to fructose and NADH (14,15). Hor-
ecker (14) described a mannitol assay based on the colo-
rimetric determination of the fructose formed as a reac-
tion product. A sensitivity down to 0.5 mmol/1 manni-
tol was attainable but a sample incubation time of 3 h
was required, followed by a color reaction for fructose.
Since the Michaelis constant for mannitol is 40-60
mmol/1 (14,15), the utility of spectrophotometric assays
based on the complete oxidation of mannitol to fructose
may be limited by excessive time requirements or the
need for large amounts of enzyme. Also, partially puri-
fied samples of mannitol dehydrogenase contain NADH
oxidase acitivity (W. G. Niehaus, unpublished work) thus
eliminating the possibility of quantitating mannitol on
the basis of total mannitol-dependent NADH formation.
However, at mannitol levels significantly below the Michae-
lis constant the initial rate of NADH formation is linear-
ly dependent on mannitol concentration and even in the
presence of low levels of NADH oxidase activity, an ini-
tial velocity can be easily determined. We describe here
a method based on this principle.
Materials and Methods
Materials
Coomassie Brilliant Blue G, D-mannitol, bicine (Í,Í-bis (2-hy-
droxyethyl)-glycine), and trishydroxymethyl amino methane
were purchased from Sigma Chemical Co., St. Louis, Mo. NAD
was from P-L Biochemicals, Inc., Milwaukee, WI. Celite 545 was
from Sargent-Welch Scientific Co., Skokie, IL and diethylamino-
ethyl-cellulose (DE-23) was a product of Whatman Inc., Clifton,
NJ.
Protein assay
Protein was measured by the method of Bradford (16) based on
the binding of Coomassie Brilliant Blue G. Bovine serum albu-
min was used as the protein standard.
Serum glucose determinations
The levels of glucose in dog serum samples were measured in the
Clinical Chemistry Laboratories of St. Paul-Ramsey Medical
Center by an automated glucose oxidase method.
Assay of mannitol dehydrogenase activity
NADH formation was recorded at 340 nm on a Gilford Model
240 spectrophotometer fitted with a Model 6040 recorder. Re-
actions were run at room temperature.
For routine assays during enzyme preparation reaction mixtures
were prepared by combining 2.5 ml of 0.5 mol/1 mannitol in 50
mmol/1 trishydroxymethyl aminomethane, pH 8.6, and 0.2 ml
of 10 mmol/1 NAD. Reaction was started by the addition of an
aliquot of enzyme solution sufficient to produce an absorbance
change of approximately 0.05 per minute. A unit of mannitol
dehydrogenase activity catalyzed the reduction of one micro-
mole of NAD in one minute.
Preparation of mannitol dehydrogenase
Lactobacillus brevis (ATCC 367) was grown as described by
Horecker (14) and cells were collected by batch ceritrifugation.
Details of a typical procedure are given below and recovery data
and specific activities are summarized in table 1.
From 301 of culture medium we obtained 50 g wet weight of
cells. These were suspended in 200 ml of buffer composed of
1 mmol/1 EDTA, 1 mmol/1 2-mercaptoethanol and 25 mmol/1
potassium phosphate, pH 6.8 (buffer A).
Cells were disrupted by sonication for 15 min in the presence
of 250 g of glass beads. The temperature was maintained below
15 °C during sonication. All subsequent purification steps were
carried out at 4°C.
After centrifugation of the sonicate at 10000 g for 30 min the
clear extract, containing 24000 units of mannitol dehydroge-
nase activity, was applied to a 40 X 100 mm column of DE-23
which had been equilibrated at pH 6.8 with buffer A. The co-
lumn was washed with 200 ml of buffer A and mannitol dehy-
drogenase activity then eluted with a linear salt gradient pre-
pared from 200 ml each of buffer A and buffer A plus 0.5 mol/1
KC1. Acitve fractions were pooled (16000 units) and subjected
to further purification by ammonium Sulfate gradient solubili-
zation (17,18), as follows.
The pooled eluate, 250 ml, was mixed with 10 g of Celite 545
and solid ammonium sulfate added to a final concentration of
3 mol/1. The resultant slurry was stirred at 4 °C for several hours
and then poured into a glass column. After the Celite 545-pro-
tein slurry had settled into a column, it was washed with 50-
100 ml of 3 mol/1 ammonium sulfate. Mannitol dehydrogenase
activity was then eluted by solubilization in a linear reverse gra-
dient of ammonium sulfate from 3 mol/1 to 1 mol/1. Active frac-
tions were pooled to give 15 000 units of activity with a speci-
fic activity of 55 units per mg of protein, this specific activity
was 75% of that reported by Horecker (14) for the 3 X-crystal-
lized enzyme. The preparation also contains a trace of NADH
oxidase activity. Enzyme was stable for at least eight months.
Mannitol infusion and preparation of serum samples
For mannitol infusion studies dogs were fasted overnight. Then,
under pentobarbital anesthesia (30 mg/kg body weight), the ani-
mals were injected intravenously with a single dose of mannitol
(0.5-2.0 g/kg body weight given as 200 g/1 mannitol solution).
Tab. 1. Preparation of mannitol dehydrogenase. Expert
mental details are given under Materials and
Methods.
Total Total Specific Recovery
protein activity activity
(mg) (U) (U/mg) (%)
10000*
supernate
DE-23 column
fractions
Ammonium sulfate
gradient fractions
12000
800
273
24000
16000
15000
2.0
20.0
55.0
100
67
" 62
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The injection time was less than 15s. Blood samples were drawn
at 30 s after the injection and at intervals thereafter. These were
centrifuged and the supernatant serum fractions stored frozen
until analyzed. Prior to assay the thawed samples were clarified
by a 10 min centrifugation at 1800^.
Assay of serum mannitol
A stock enzyme reagent solution composed of enzyme (5-25
mg/1 protein), 0.12 mol/1 bicine, pH 9.0, an optimal pH for
mannitol oxidation (14,15), and 1.2 mmol/1 NAD was prepared
and incubated at room temperature for 30—45 min. During this
incubation background reactions yielding NADH in the absence
of added mannitol were completed such that no further change
in absorbance at 340 nm was observed in the absence of added
serum or mannitol standard. The decrease in NAD during this
pre-incubation was 2-3% or less of the total present.
Aliquots (2.9 ml) of this reagent solution were added to cuvettes
which were then placed in the sample chamber of the spectro-
photometer. Absorbance at 340 nm was recorded for 2—3 minutes
after which reaction was started by the addition of 100 ìÀ of
serum or mannitol standard. The change on absorbance was re-
corded for 3—5 minutes. Initial velocities were determined from
tangents constructed to the first 2-3 minutes of the reaction
progression curves.
Results
Standard curves
Standard curves for two ranges of mannitol concentra-
tons, 0.017-0.833 and 0.33-6.67 mmol/1, are shown in
figure 1. The initial rate of NADH formation was a linear
function of mannitol concentration up to at least 6.67
mmol/1. A lower limit of 17 ìðéüÀ/À was detectable.
Considering the 40-fold dilution of the serum sample in
the, assay, the data in figure 1 are equivalent to a range
of serum mannitol levels of 0.5-200 mmol/1. This lower
value of 0.5 mmol/1, adequate for pur purposes, was at-
tained with a recorder full-scale range of 0.0—0.3 absor-
bance unit. Further sensitivity could be achieved by re-
ducing this to 0.0—0.1 and/or increasing the volume of
serum analyzed.
No reaction could be detected with serum samples to
which no mannitol had been added. Mannitol is detec-
table in only trace amounts in normal human serum (10,
13) and pur results are consistent with a similar conclu-
sion with regard to dog serum.
Effects of serum on mannitol quantitation
Mannitol dehydrogenase exhibits a high degree of sub-
strate spe'cifieity and does not react with various polyol
compounds which might be present in serum, such as
glucose, sofbitol, iriositol or xylitol (14,15). However,
glucose was present at 4.3—5.7 mmol/1 in the serum
samples used in this study and the extent to which com-
pounds of this type might bind to the actiye site of the
enzyme and inhibit reaction has not been extensively in-
vestigated. To consider this question standards were es-
sayed in the presence and absence of added serum. As
shown in figure 2 the mannitol standard curve was not
affected by serum at the level used in the usual assay
c
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Fig. 1. Standard curves. Assays were done as described under
Materials and Methods.
a) Mannitol dehydrogenase was at 5 mg/1 protein. Data
points are mean values of three determinations each at
0.33, 0.83, 1.67, 5.00 and 6.67 mmol/1 mannitoi. The
slope of the line is based on the mean value of
ÄÁ · min"1 · mmoF1 · 1 (n = 15) and equals 0.0114.
The standard deviation is 0.0013 and the coefficient
of variation is 11.4%.
b) Mannitol dehydrogenase was at 22 mg/1 protein. Data
points are mean values of 2-5 replicates at 0.033,
0.067, 0.333 and 0.833 mmol/1 mannitol. The slope
of the lines in the figure and inset is based on a mean
value for Ä A · min"1 · mmol"1 · 1 of 0.1182 (n = 17).
The standard deviation is 0.0092 and the coefficient
of variation equals 7.8%. The data points in the inset
:
 are for 0,017, 0.033 and 0.067 mmol/1 mannitoL
mixture. Thus it is not necessary to deproteinize the se-
rum or to attempt to remove glucose.
Determination of mannitol added in vitro to serum
obtained after mannitol infiision
To estimate recovery, known amounts of mannitol were
added to serum samples from dogs which had been pre-
viously infused with mannitol. Data are given in table 2.
The total amounts observed after the addition of manni-
tol were 86-100% of the calculated sums of mannitol
present plus mannitol added.
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Fig. 2. Initial velocities observed with mannitol standards
assayed in the presence and absence of serum.
Reaction mixtures (3.0 ml) contained 21 mg/1 mannitol
dehydrogenase and 0.1 ml of dog serum (·) or water (o).
The line represents the average initial velocity of
0.0711 · mmol"1 · min"1. The average deviation of
duplicate assays was 5.7%.
Tab. 2. Recovery of mannitol added to serum samples contain-
ing mannitol.
Assays were run as described unter Materials and Methods.
Reaction mixtures of 3.0 ml total volume contained 100
ìÀ of dog serum. The data are mean values ± standard de-
viation for ç determinations. CV = coefficient of varia-
tion.
Sample
1
2
3
4
5
6
Mannitol
added
(mmol/1)
0
20
0
20
0
20
0
20
0
20
0
20
Mannitol
observed
(mmol/1)
34.8 ± 3.4
51.2 ±4.4
28.1 ± 2.7
42.2 ± 4.0
10.1 ± 2.5
25.9 é 3.2
132.5 ± 6.4
151.1 ± 6.2
76.3 ± 6.7
99.3 ± 6.0
30.7 ± 2.8
47.7 ± 3.6
ç
2
2
2
2
2
2
8
8
7
9
8
7
CV
(%)
9.7
8.6
9.6
9.5
24.7
12.3
4.8
4.1
8.7
6.0
9.1
7.5
Mannitol levels in dog serum following infusion
The application of the method to following mannitol
levels in dogs is illustrated in figure 3. Aliquots of 100 ìÀ
were taken from serum samples drawn at intervals after
mannitol injection. A maximum level was reached by 1
minute after the completion of the injection. The manni-
tol concentration decreased rapidly to approximately 50
% of this peak by 4-5 minutes. It then decreased more
slowly and was undetectable at 90 min.
Discussion
Nasrallah &Iber (19) used both a colorimetric method
(6) and 14C-labeled mannitol to measure the distribution
10.0
-8.0
.16.0
ï
4.0
2.0
QO 20 40 60
t (min]
80 100
Fig. 3. Serum mannitol levels as a function of time after a single
injection of mannitol.
Zero time was taken as the completion of the injection.
Blood was drawn and samples analyzed as described under
Materials and Methods.
Mannitol dehydrogenase was at 22 mg/1 in the reaction
mixtures.
in serum, urine and feces of mannitol ingested orally by
human volunteers. They pointed out that both appro-
aches have serious shortcomings; the colorimetric assay
because of high and variable "blank" reactions and the
isotopic method because one cannot distinguish manni-
tol from its metabolites unless a fractionation procedure
is used.
Due to the high degree of substrate specificity expressed
by mannitol dehydrogenase, problems of interfering sub-
stances and ambiguous identities of reactants are greatly
reduced in an enzymatic assay. And, by making use of
initial velocities, problems arising from the high Michae-
lis constant for mannitol and from side reactions cata-
lyzed by other enzymes in the mannitol dehydrogenase
preparations are largely avoided. Another important ad-
vantage of the enzymatic method as described here is the
lack of a need for sample deproteinization or the remo-
val of glucose.
The rate of NADH formation is linear for at least 2—3
minutes but deviates from linearity at later times due to
the presence of an undefined NADH oxidase activity in
the mannitol dehydrogenase preparations. Because of
this the assay was based on initial velocities estimated
by constructing tangents to the initial portions of the
progression curves. However, fixed-time assays based on
net increase in absorbance during the first five minutes
of reaction have given results equivalent to those from
initial velocity estimates.
As indicated in the description of the. assay procedure
under Materials and Methods, there is some NADH for-
mation in reaction mixtures lacking-serum or added
mannitol but which contain buffer, NAD and enzyme.
We do not know the basis for this reaction. One· possible
explanation is that an impurity in the NAD prepara-
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tion, such as ethanol (20), is reacting with a second en-
zyme in the mannitol dehydrogenase preparation. In
the procedure described here, this reaction will not con-
tribute significantly to estimates of the initial rate of
NADH formation if a pre-incubation is carried out.
The rapid increase and subsequent two-phase decrease
in serum mannitol after a single injection (fig. 3) are con-
sistent with previous data from human subjects (7,19,
21). The biphasic character of the decrease has been in-
terpreted as due first to a rapid equilibration of the
mannitol into the tissue space followed by a second,
slower phase representing metabolism and excretion in-
to the urine.
With the enzymatic assay procedure described here, data
as shown in figure 3 are obtained simply with readily
available instrumentation. The analyses illustrated in
figure 3 were completed within 90 min.
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